Men with good functional results following radical retropubic prostatectomy (RRP) and requiring radical cystectomy (RC) for subsequent bladder carcinoma seldom receive orthotopic bladder substitution. Four patients aged 62- 72 years (median 67 years), who had undergone RRP for prostate cancer of stage pT2bN0M0 Gleason score 6 (n = 1), pT2cN0M0 Gleason score 5 and 6 (n = 2) and pT3bN0M0 Gleason score 7 (n = 1) 27 to 104 months before, developed urothelial bladder carcinoma treated with RC and ileal orthotopic bladder substitution. After radical prostatectomy three were continent and one had grade I stress incontinence, and three achieved intercourse with intracavernous alprostadil injections. Follow-up after RC ranged between 27 and 42 months (median 29 months). At the 24-month follow-up visit after RC daily urinary continence was total (0 pad) in one patient, two used one pad for mild leakage, and one was incontinent following endoscopic incision of anastomotic stricture. One patient died of progression of bladder carcinoma, while the other three are alive without evidence of disease. The three surviving patients continued to have sexual intercourse with intracavernous alprostadil injections. Men with previous RRP have a reasonable chance of maintaining a satisfactory functional outcome following RC and ileal orthotopic bladder substitution.

Keywords:
Bladder cancer, Prostate cancer, Prostatectomy, Radical cystectomy, Ileal neobladder, Reconstruction, Continence, Sexual function
1.
Schuster TG, Marcovich R, Sheffield J, Montie JE, Lee CT: Radical cystectomy for bladder cancer after definitive prostate cancer treatment. Urology 2003;61:342-347.
2.
Miotto A Jr, Dall'Oglio M, Srougi M: Cystectomy with orthotopic reconstruction following retropubic prostatectomy. Int Braz J Urol 2004;30:125-127.
3.
Jayram G, Katz MA, Steinberg GD: Radical cystectomy in patients previously treated for localized prostate cancer. Urology 2010;76:1430-1433.
4.
Huang EY, Skinner EC, Boyd SD, Cai J, Miranda G, Daneshmand S: Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy. World J Urol 2012;30:741-745.
5.
Studer UE, Burkhard FC, Schumacher M, Kessler TM, Thoeny H, Fleischmann A, Thalmann GN: Twenty years experience with an ileal orthotopic low pressure bladder substitute - lessons to be learned. J Urol 2006;176:161-166.
6.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
7.
Burkhard FC, Kessler TM, Fleischmann A, Thalmann GN, Schumacher M, Studer UE: Nerve sparing open radical retropubic prostatectomy: does it have an impact on urinary continence? J Urol 2006;176:189-195.
8.
Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, Studer UE: Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004;172:1323-1327.
9.
Noldus J, Graefen M, Haese A, Henke RP, Hammerer P, Huland H: Stage migration in clinically localized prostate cancer. Eur Urol 2000;38:74-78.
10.
Cooperberg MR, Broering JM, Carrol PR: Time trends and local variations in primary treatment of localized prostate cancer. J Clin Oncol 2010;28:1117-1123.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.